ATA Guidelines Tools

Recurrent / Persistent Nodal Disease

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/631818

Contents of this Issue

Navigation

Page 2 of 3

Diagnosis Table 1. Variables to Consider When Deciding How Best to Manage a Differentiated Thyroid Cancer Patient with Recurrent/Persistent Nodal Disease (cont'd) Variables Consider active surveillance Consider surgery Comorbidities for surgery Yes No Invasion into/proximity to critical anatomic structures No Yes Good long-term prognosis No Yes Patient wishes to undergo surgery No Yes Disease likely to be identified intraoperatively No Yes Biological considerations RAI-avid b Yes No (unless other criteria for surgery met) FDG-PET-avid No Yes Aggressive histolog y No Yes Extrathyroidal extension of primary tumor No Yes More advanced initial T stage (>4 cm) and more advanced nodal disease No Yes Extranodal extension (features of nodes at initial surgery) No Yes Molecular prognosticator for aggressive biolog y (see full text of article) No Yes Surgical technical considerations First recurrence in that compartment? No Yes Recurrent or persistent disease in previously formally dissected compartment or multiple dissections in same compartment c Stable disease Limited/focused dissection if progressive disease and threatening important structures a Most authors agree that nodes <1 cm can usually be observed. However, depending on the unique situation of each patient, it may be reasonable to avoid surgery on nodes as large as 1.5–2 cm in carefully selected patients. b Active surveillance or RAI therapy are both reasonable options if the lymph node metastasis is RAI-avid. c Initial intervention was a formal attempt at central or lateral neck dissection and not just a node plucking or limited retrieval of nodes.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Recurrent / Persistent Nodal Disease